Dabrafenib/trametinib
Fields of Study & Subjects
Melanoma and MAPK Pathways
Pharmacovigilance and Adverse Drug Reactions
Protein Degradation and Inhibitors
Publication details
- Journal / source
- Reactions Weekly
- Volume
- 2099
- Issue
- 1
- Pages
- 42–42
- Publication date
- 26 February 2026
- Language
- EN